About us
Our Team
Our Board of Directors
Our Scientific Advisory Board
Our Collaborations
Technology
Meet ALIGATER
Manufacturing
pipeline
Neurodegenerative Diseases
Ocular Diseases
News
Press Releases
Careers
Contact
About us
Our Team
Our Board of Directors
Our Scientific Advisory Board
Our Collaborations
Technology
Meet ALIGATER
Manufacturing
pipeline
Neurodegenerative Diseases
Ocular Diseases
News
Press Releases
Careers
Contact
Category
Press Releases
30
May
Coave Therapeutics announces Positive 12-months Data from Ongoing Phase I/II Clinical Trial of CTx-PDE6b in Patients with Retinitis Pigmentosa Caused by Bi-allelic Mutations in PDE6b
30 May 2023
coavetx
Press Releases
Read More
04
May
Coave Therapeutics Demonstrates its Modified coAAV Vectors Outperform AAV9 to Address Neurological Disorders
4 May 2023
coavetx
Press Releases
Read More
16
Mar
Coave Therapeutics to Present at Upcoming Conferences
16 March 2023
coavetx
Events
,
Press Releases
Read More
20
Sep
Coave Therapeutics to Present at Chardan’s 6th Annual Genetic Medicines Conference
20 September 2022
coavetx
Events
,
Press Releases
Read More
12
Sep
Coave Therapeutics to Collaborate with World-Renowned Institute of Neurodegenerative Diseases of Bordeaux to Develop Gene Therapy Programs Targeting Protein Degradation in Neurodegenerative Disorders
12 September 2022
coavetx
Press Releases
Read More
06
Sep
Coave Therapeutics Strengthens Leadership Team with the Appointments of Catherine Mathis as Vice President Regulatory Affairs and Julien Berger as Head of Legal Affairs
6 September 2022
coavetx
Press Releases
Read More
29
Jun
Coave Therapeutics Announces Formation of Scientific Advisory Board to Drive its Pipeline Strategy for Next-generation Gene Therapies Targeting CNS Diseases
29 June 2022
coavetx
Press Releases
Read More
09
Jun
Coave Therapeutics and ABL enter into strategic collaboration to develop gene therapy manufacturing processes and create joint capabilities for process development of AAV-based gene therapy
9 June 2022
coavetx
Press Releases
Read More
03
May
Coave Therapeutics to Present Data on its Chemically Engineered AAV Vectors for Gene Therapy in CNS Disease at ASCGT
3 May 2022
coavetx
Press Releases
Read More
27
Apr
Coave Therapeutics will be presenting an abstract at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting being held in Denver, Colorado 1-4 May 2022. The meeting will also be available for virtual attendees 11-12 May.
27 April 2022
coavetx
Press Releases
Read More
1
2
Home
Press Releases
Events